Ahmed F. Yazbi-El
Al `alamayn, MT 51718, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Hippocampal Mitochondrial Dysfunction and Synaptic Disruption Link Organophosphate Exposure to Pre-Diabetes: An LC-MS/MS-Based Proteomics Approach.
Journal: Biomolecules
Published: May 15, 2026
Reframing SGLT2 inhibition: Anti-inflammatory mechanisms and drug target insights emerging from EMPA-TROPISM.
Journal: The Journal of pharmacology and experimental therapeutics
Published: March 13, 2026
One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunction.
Journal: European journal of medicinal chemistry
Published: February 15, 2026
Early Prediabetes Aggravates Neuroinflammatory and Cognitive Dysfunctional Responses to Chlorpyrifos Exposure: Possible Amelioration by Arachidonic Acid.
Journal: European journal of pharmacology
Published: January 22, 2026
Corrigendum to "Glucagon-like peptide-1 agonists alleviate adenine-induced nephrotoxicity in rats: interaction with the renin-angiotensin system and role of NLRP-3 inflammasome, nephrin and KIM-1" [Biochem. Pharmacol. 242(P4) (2025) 117431].
Journal: Biochemical pharmacology
Published: November 23, 2025
Novel furanone-based anticancer agents: Design, synthesis, Hsp90 inhibition, in vivo antitumor activity and pharmacokinetic studies.
Journal: European journal of medicinal chemistry
Published: July 30, 2025
Glucagon-like peptide-1 agonists alleviate adenine-induced nephrotoxicity in rats: interaction with the renin-angiotensin system and role of NLRP-3 inflammasome, nephrin and KIM-1.
Journal: Biochemical pharmacology
Published: July 21, 2025
Mitigation of thromboinflammation by rivaroxaban ameliorates metabolic and structural manifestations of metabolic dysfunction-associated steatohepatitis in rats: Comparison to other antithrombotic drugs.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 23, 2025
Role of Endocannabinoid System Perturbation in Organophosphate-Mediated Metabolic Impairment and Neuroinflammation.
Journal: Basic & clinical pharmacology & toxicology
Published: June 08, 2025
Revisiting multi-pathway modulation with theophylline derivatives: Targeting STAT3, NF-κB, and apoptotic signaling in breast cancer.
Journal: Bioorganic chemistry
Published: April 24, 2025
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction.
Journal: ACS pharmacology & translational science
Published: January 05, 2025
Novel thiazolones for the simultaneous modulation of PPARγ, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation.
Journal: European journal of medicinal chemistry
Published: December 22, 2024
Last Updated: 09/26/2026